Yu H, Nishio H, Barbi J, Mitchell-Flack M, Vignali P, Zheng Y
Elife. 2024; 13.
PMID: 39565188
PMC: 11578584.
DOI: 10.7554/eLife.96812.
Jamison B, Lawrance M, Wang C, DeBerg H, Ziegler L, Sansom D
Cell Rep. 2024; 43(11):114938.
PMID: 39488830
PMC: 11602548.
DOI: 10.1016/j.celrep.2024.114938.
Van Der Byl W, Nussing S, Peters T, Ahn A, Li H, Ledergor G
Immunity. 2024; 57(6):1324-1344.e8.
PMID: 38776918
PMC: 11807353.
DOI: 10.1016/j.immuni.2024.04.026.
Saunders M, Rad L, Williams L, Landers J, Urie R, Hocevar S
Adv Healthc Mater. 2024; 14(5):e2400237.
PMID: 38691819
PMC: 11527797.
DOI: 10.1002/adhm.202400237.
Yu H, Nishio H, Barbi J, Mitchell-Flack M, Vignali P, Zheng Y
bioRxiv. 2024; .
PMID: 38352414
PMC: 10862906.
DOI: 10.1101/2024.01.31.578284.
Interferon regulatory factor 4 plays a pivotal role in the development of aGVHD-associated colitis.
Frueh J, Campe J, Sunaga-Franze D, Verheyden N, Ghimire S, Meedt E
Oncoimmunology. 2024; 13(1):2296712.
PMID: 38170159
PMC: 10761041.
DOI: 10.1080/2162402X.2023.2296712.
An IL-2 mutein increases IL-10 and CTLA-4-dependent suppression of dendritic cells by regulatory T cells.
Jamison B, Lawrance M, Wang C, DeBerg H, Sansom D, Gavin M
bioRxiv. 2023; .
PMID: 38106196
PMC: 10723345.
DOI: 10.1101/2023.12.01.569613.
BATF represses BIM to sustain tolerant T cells in the periphery.
Titcombe P, Morales M, Zhang N, Mueller D
J Exp Med. 2023; 220(12).
PMID: 37862030
PMC: 10588758.
DOI: 10.1084/jem.20230183.
Synthetically glycosylated antigens for the antigen-specific suppression of established immune responses.
Tremain A, Wallace R, Lorentz K, Thornley T, Antane J, Raczy M
Nat Biomed Eng. 2023; 7(9):1142-1155.
PMID: 37679570
DOI: 10.1038/s41551-023-01086-2.
Molecular, metabolic, and functional CD4 T cell paralysis in the lymph node impedes tumor control.
Guo M, Abd-Rabbo D, Bertol B, Carew M, Lukhele S, Snell L
Cell Rep. 2023; 42(9):113047.
PMID: 37651234
PMC: 10578141.
DOI: 10.1016/j.celrep.2023.113047.
Therapy targeting antigen-specific T cells by a peptide-based tolerizing vaccine against autoimmune arthritis.
Urbonaviciute V, Romero-Castillo L, Xu B, Luo H, Schneider N, Weisse S
Proc Natl Acad Sci U S A. 2023; 120(25):e2218668120.
PMID: 37307481
PMC: 10288627.
DOI: 10.1073/pnas.2218668120.
Mutation of the glycine residue preceding the sixth tyrosine of the LAT adaptor severely alters T cell development and activation.
Arbulo-Echevarria M, Vico-Barranco I, Zhang F, Fernandez-Aguilar L, Chotomska M, Narbona-Sanchez I
Front Immunol. 2022; 13:1054920.
PMID: 36569841
PMC: 9768323.
DOI: 10.3389/fimmu.2022.1054920.
Distinct myeloid antigen-presenting cells dictate differential fates of tumor-specific CD8+ T cells in pancreatic cancer.
Burrack A, Schmiechen Z, Patterson M, Miller E, Spartz E, Rollins M
JCI Insight. 2022; 7(7).
PMID: 35393950
PMC: 9057584.
DOI: 10.1172/jci.insight.151593.
Tolerogenic Delivery of a Hybrid Insulin Peptide Markedly Prolongs Islet Graft Survival in the NOD Mouse.
Jamison B, DiLisio J, Beard K, Neef T, Bradley B, Goodman J
Diabetes. 2022; 71(3):483-496.
PMID: 35007324
PMC: 8893950.
DOI: 10.2337/db20-1170.
ZAP70, too little, too much can lead to autoimmunity.
Ashouri J, Lo W, Nguyen T, Shen L, Weiss A
Immunol Rev. 2021; 307(1):145-160.
PMID: 34923645
PMC: 8986586.
DOI: 10.1111/imr.13058.
A Role for Folate in Microbiome-Linked Control of Autoimmunity.
Molzer C, Wilson H, Kuffova L, Forrester J
J Immunol Res. 2021; 2021:9998200.
PMID: 34104654
PMC: 8159645.
DOI: 10.1155/2021/9998200.
Role of the Orphan Nuclear Receptor NR4A Family in T-Cell Biology.
Odagiu L, May J, Boulet S, Baldwin T, Labrecque N
Front Endocrinol (Lausanne). 2021; 11:624122.
PMID: 33597928
PMC: 7883379.
DOI: 10.3389/fendo.2020.624122.
Immune Privilege: The Microbiome and Uveitis.
Molzer C, Heissigerova J, Wilson H, Kuffova L, Forrester J
Front Immunol. 2021; 11:608377.
PMID: 33569055
PMC: 7868421.
DOI: 10.3389/fimmu.2020.608377.
Targeting transcriptional coregulator OCA-B/Pou2af1 blocks activated autoreactive T cells in the pancreas and type 1 diabetes.
Kim H, Perovanovic J, Shakya A, Shen Z, German C, Ibarra A
J Exp Med. 2020; 218(3).
PMID: 33295943
PMC: 7731945.
DOI: 10.1084/jem.20200533.
Pathogen-reduced PRP blocks T-cell activation, induces Treg cells, and promotes TGF-β expression by cDCs and monocytes in mice.
Tran J, Muench M, Jackman R
Blood Adv. 2020; 4(21):5547-5561.
PMID: 33166410
PMC: 7656940.
DOI: 10.1182/bloodadvances.2020002867.